Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 13, 2021

View Archived Issues

Equillium presents additional data from EQUALISE study of itolizumab

ON-108600 leads to potent tumor growth inhibition in chemotherapy-resistant TNBC models

Phase Ib/II data reported from CARTITUDE-1 study of ciltacabtagene autoleucel

Preclinical data confirm survival benefit of adding Veyonda to LuPSMA in prostate cancer

lncRNA HULC linked to phenylketonuria prevention, HULC-mimetics show therapeutic promise

B-Raf, MEK1 inhibitors discovered at Chugai

Shenzhen Salubris Pharmaceuticals presents new cathepsin K inhibitors

Shanghai Hengrui Pharmaceutical and others patent ADCs with eribulin derivatives

SSAO inhibitors identified at Shanghai Ennova Biopharmaceutical, Ennovabio Pharmaceuticals

VYNE and In4Derm enter licence agreement for discovery and development of BET inhibitor platform

FDA clears IND application for first-in-human trial of IO-108

Mustang Bio and Mayo Clinic collaborate on development of novel CAR T technology

Sen-Jam and Duke-NUS Medical School partner to develop novel COVID-19 therapy

Cogent initiates phase II study of CGT-9486 in systemic mastocytosis

Nimbus and Schrödinger extend drug discovery collaboration

Moderna initiates phase I/II study of mRNA-3705 in methylmalonic acidemia

Phase I/II study of ChulaCov19 vaccine initiates at Chulalongkorn University

SARS-CoV-2 spike ectodomain protein StriFK vaccine with adjuvant reduces transmission in animals

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...